Perma-Fix Northwest Richland, Inc., 51386-51387 [2021-19840]

Download as PDF 51386 Federal Register / Vol. 86, No. 176 / Wednesday, September 15, 2021 / Notices evaluation, and recommendations on financial assistance under the National Foundation on the Arts and the Humanities Act of 1965, as amended, including information given in confidence to the agency. In accordance with the determination of the Chairman of September 10, 2019, these sessions will be closed to the public pursuant to subsection (c)(6) of section 552b of title 5, United States Code. The upcoming meetings are: American Rescue Plan Locals Subgranting (review of applications): This meeting will be closed. Date and time: October 4, 2021, 1:00 p.m. to 3:00 p.m. American Rescue Plan Locals Subgranting (review of applications): This meeting will be closed. Date and time: October 4, 2021, 3:30 p.m. to 5:30 p.m. Dated: September 10, 2021. Sherry P. Hale, Staff Assistant, National Endowment for the Arts. [FR Doc. 2021–19893 Filed 9–14–21; 8:45 am] BILLING CODE 7537–01–P NUCLEAR REGULATORY COMMISSION I. Obtaining Information and Submitting Comments [Docket No. 11006420; NRC–2021–0163] Perma-Fix Northwest Richland, Inc. Nuclear Regulatory Commission. ACTION: Export license application; opportunity to provide comments, request a hearing, and petition for leave to intervene. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) received and is considering issuing an export license (XW028) requested by Perma-Fix Northwest Richland, Inc. (PFNW). On July 2, 2021, PFNW filed an application with the NRC for a license authorizing the export of low-level radioactive waste to Nordion (Canada) Inc., Canada. The NRC is providing notice of the opportunity to comment, request a hearing, and petition to intervene on PFNW’s application. DATES: Submit comments by October 15, 2021. A request for a hearing or a petition for leave to intervene must be filed by October 15, 2021. ADDRESSES: You may submit comments by any of the following methods; however, the NRC encourages electronic comment submission through the Federal Rulemaking website: khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:08 Sep 14, 2021 Jkt 253001 • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2021–0163. Address questions about Docket IDs in Regulations.gov to Stacy Schumann; telephone: 301–415–0624; email: Stacy.Schumann@nrc.gov. For technical questions contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • Email comments to: Hearing.Docket@nrc.gov. If you do not receive an automatic email reply confirming receipt, then contact us at 301–415–1677. • Fax comments to: Secretary, U.S. Nuclear Regulatory Commission at 301– 415–1101. • Mail comments to: Secretary, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001, ATTN: Rulemakings and Adjudications Staff. For additional direction on obtaining information and submitting comments, see ‘‘Obtaining Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. FOR FURTHER INFORMATION CONTACT: Gary Langlie, Office of International Programs, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001; telephone: 301–287–9076, email: Gary.Langlie@nrc.gov. SUPPLEMENTARY INFORMATION: A. Obtaining Information Please refer to NRC–2021–0163 or Docket No. 11006420 when contacting the NRC about the availability of information for this action. You may obtain publicly available information related to this action by the following methods: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2021–0163. • NRC’s Public Website: Go to https:// www.nrc.gov and search for XW028, Docket No. 11006420, or Docket ID NRC–2021–0163. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publicly available documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301– 415–4737, or by email to pdr.resource@ nrc.gov. The export license application from PFNW is available in ADAMS under Accession No. ML21190A131. PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 • The PDR, where you may examine and order copies of public documents, is currently closed. You may submit your request to the PDR via email at pdr.resource@nrc.gov or call 1–800– 397–4209 or 301–415–4737, between 8:00 a.m. and 4:00 p.m. (ET), Monday through Friday, except Federal holidays. B. Submitting Comments The NRC encourages electronic comment submission through the Federal Rulemaking website (https:// www.regulations.gov). Please include NRC–2021–0163 or Docket No. 11006420 in your comment submission. The NRC cautions you not to include identifying or contact information that you do not want to be publicly disclosed in your comment submission. The NRC will post all comment submissions at https:// www.regulations.gov as well as enter the comment submissions into ADAMS. The NRC does not routinely edit comment submissions to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the NRC, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment into ADAMS. II. Discussion On July 8, 2021, the NRC received an application from PFNW requesting a specific license to export low-level radioactive waste to Canada. The application seeks authorization to export no greater than 1,379,102 kilograms and 3.99 terabecquerels (TBq) of liquid low-level radioactive waste generated from medical isotope and radiopharmaceuticals production. The application requests an expiration date of December 1, 2026. In accordance with section 110.70 paragraph (b) of title 10 of the Code of Federal Regulations (10 CFR) the NRC is providing notice of the receipt of the application; providing the opportunity to submit written comments concerning the application; and providing the opportunity to request a hearing or petition for leave to intervene, for a period of 30 days after publication of this notice in the Federal Register. A hearing request or petition for leave to intervene must include the information specified in 10 CFR 110.82(b). Any request for hearing or petition for leave E:\FR\FM\15SEN1.SGM 15SEN1 Federal Register / Vol. 86, No. 176 / Wednesday, September 15, 2021 / Notices to intervene shall be served by the requestor or petitioner in accordance with 10 CFR 110.89(a), either by delivery, by mail, or filed with the NRC electronically in accordance with the NRC’s E-Filing rule (72 FR 49139; August 28, 2007, as amended at 77 FR 46562; August 3, 2012). Detailed guidance on making electronic submissions may be found in the Guidance for Electronic Submissions to the NRC and on the NRC website at https://www.nrc.gov/site-help/esubmittals.html. To comply with the procedural requirements of E-Filing, at least 10 days prior to the filing deadline, the participant should contact the Office of the Secretary by email at Hearing.Docket@nrc.gov, or by telephone at 301–415–1677, to (1) request a digital identification (ID) certificate, which allows the participant (or its counsel or representative) to digitally sign submissions and access the E-Filing system for any proceeding in which it is participating; and (2) advise the Secretary that the participant 51387 will be submitting a petition or other adjudicatory document (even in instances in which the participant, or its counsel or representative, already holds an NRC-issued digital ID certificate). Based upon this information, the Secretary will establish an electronic docket for the hearing in this proceeding if the Secretary has not already established an electronic docket. The information concerning this application for an export license follows. NRC EXPORT LICENSE APPLICATION Application Information Name of Applicant .............................................. Date of Application ............................................. Date Received .................................................... Application No ..................................................... Docket No ........................................................... ADAMS Accession No ........................................ Perma-Fix Northwest Richland, Inc. (PFNW). July 2, 2021. July 8, 2021. XW028. 11006420. ML21190A131. Description of Material Material Type ...................................................... Total Quantity ..................................................... End Use .............................................................. Country of Destination ........................................ Dated: September 9, 2021. For the Nuclear Regulatory Commission. David L. Skeen, Deputy Director, Office of International Programs. to BWXT Medical, Ltd., Canada. The NRC is providing notice of the opportunity to comment, request a hearing, and petition to intervene on PFNW’s application. [FR Doc. 2021–19840 Filed 9–14–21; 8:45 am] DATES: Submit comments by October 15, 2021. A request for a hearing or a petition for leave to intervene must be filed by October 15, 2021. BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Perma-Fix Northwest Richland, Inc. Nuclear Regulatory Commission. ACTION: Export license application; opportunity to provide comments, request a hearing, and petition for leave to intervene. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) received and is considering issuing an export license (XW029) requested by Perma-Fix Northwest Richland, Inc. (PFNW). On July 2, 2021, PFNW filed an application with the NRC for a license authorizing the export of low-level radioactive waste SUMMARY: VerDate Sep<11>2014 17:08 Sep 14, 2021 You may submit comments by any of the following methods; however, the NRC encourages electronic comment submission through the Federal Rulemaking website: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2021–0164. Address questions about Docket IDs in Regulations.gov to Stacy Schumann; telephone: 301–415–0624; email: Stacy.Schumann@nrc.gov. For technical questions contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • Email comments to: Hearing.Docket@nrc.gov. If you do not receive an automatic email reply confirming receipt, then contact us at 301–415–1677. ADDRESSES: [Docket No. 11006421; NRC–2021–0164] khammond on DSKJM1Z7X2PROD with NOTICES Radioactive material consisting of liquid waste generated from medical isotope and radiopharmaceuticals production. The treated waste exported to Canada consists mainly of thermal treatment residual (ash) and some non-combustible metal. Authorization to export a total maximum quantity of waste will not exceed 1,379,102 kilograms. The maximum isotopic activity returned will be 3.99 TBq. Radionuclides potentially present in the waste include: Cd-115, Co-60, Cr-51, Cu-64, ln-115m, K-42, Mo-93m, Mo-99, Nb91m, Nb-92m, Nb-95, Nb-95m, Nb-96, Re-188, Sb-122, Sb-124, Ta-182, Ta-183, Tc-99m, W-185, W-187, W-188, and Zr-89. Disposal in Canada. Canada. Jkt 253001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 • Fax comments to: Secretary, U.S. Nuclear Regulatory Commission at 301– 415–1101. • Mail comments to: Secretary, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001, ATTN: Rulemakings and Adjudications Staff. For additional direction on obtaining information and submitting comments, see ‘‘Obtaining Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. FOR FURTHER INFORMATION CONTACT: Gary Langlie, Office of International Programs, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001; telephone: 301–287–9076, email: Gary.Langlie@nrc.gov. SUPPLEMENTARY INFORMATION: I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to NRC–2021–0164 or Docket No. 11006421 when contacting the NRC about the availability of information for this action. You may obtain publicly available information E:\FR\FM\15SEN1.SGM 15SEN1

Agencies

[Federal Register Volume 86, Number 176 (Wednesday, September 15, 2021)]
[Notices]
[Pages 51386-51387]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19840]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 11006420; NRC-2021-0163]


Perma-Fix Northwest Richland, Inc.

AGENCY: Nuclear Regulatory Commission.

ACTION: Export license application; opportunity to provide comments, 
request a hearing, and petition for leave to intervene.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) received and is 
considering issuing an export license (XW028) requested by Perma-Fix 
Northwest Richland, Inc. (PFNW). On July 2, 2021, PFNW filed an 
application with the NRC for a license authorizing the export of low-
level radioactive waste to Nordion (Canada) Inc., Canada. The NRC is 
providing notice of the opportunity to comment, request a hearing, and 
petition to intervene on PFNW's application.

DATES: Submit comments by October 15, 2021. A request for a hearing or 
a petition for leave to intervene must be filed by October 15, 2021.

ADDRESSES: You may submit comments by any of the following methods; 
however, the NRC encourages electronic comment submission through the 
Federal Rulemaking website:
     Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2021-0163. Address 
questions about Docket IDs in Regulations.gov to Stacy Schumann; 
telephone: 301-415-0624; email: [email protected]. For technical 
questions contact the individual listed in the FOR FURTHER INFORMATION 
CONTACT section of this document.
     Email comments to: [email protected]. If you do not 
receive an automatic email reply confirming receipt, then contact us at 
301-415-1677.
     Fax comments to: Secretary, U.S. Nuclear Regulatory 
Commission at 301-415-1101.
     Mail comments to: Secretary, U.S. Nuclear Regulatory 
Commission, Washington, DC 20555-0001, ATTN: Rulemakings and 
Adjudications Staff.
    For additional direction on obtaining information and submitting 
comments, see ``Obtaining Information and Submitting Comments'' in the 
SUPPLEMENTARY INFORMATION section of this document.

FOR FURTHER INFORMATION CONTACT: Gary Langlie, Office of International 
Programs, U.S. Nuclear Regulatory Commission, Washington, DC 20555-
0001; telephone: 301-287-9076, email: [email protected].

SUPPLEMENTARY INFORMATION:

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to NRC-2021-0163 or Docket No. 11006420 when 
contacting the NRC about the availability of information for this 
action. You may obtain publicly available information related to this 
action by the following methods:
     Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2021-0163.
     NRC's Public Website: Go to https://www.nrc.gov and search 
for XW028, Docket No. 11006420, or Docket ID NRC-2021-0163.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS 
Search.'' For problems with ADAMS, please contact the NRC's Public 
Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or 
by email to pdr[email protected]. The export license application from 
PFNW is available in ADAMS under Accession No. ML21190A131.
     The PDR, where you may examine and order copies of public 
documents, is currently closed. You may submit your request to the PDR 
via email at [email protected] or call 1-800-397-4209 or 301-415-
4737, between 8:00 a.m. and 4:00 p.m. (ET), Monday through Friday, 
except Federal holidays.

B. Submitting Comments

    The NRC encourages electronic comment submission through the 
Federal Rulemaking website (https://www.regulations.gov). Please 
include NRC-2021-0163 or Docket No. 11006420 in your comment 
submission.
    The NRC cautions you not to include identifying or contact 
information that you do not want to be publicly disclosed in your 
comment submission. The NRC will post all comment submissions at 
https://www.regulations.gov as well as enter the comment submissions 
into ADAMS. The NRC does not routinely edit comment submissions to 
remove identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the NRC, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that the NRC does not routinely edit comment submissions to 
remove such information before making the comment submissions available 
to the public or entering the comment into ADAMS.

II. Discussion

    On July 8, 2021, the NRC received an application from PFNW 
requesting a specific license to export low-level radioactive waste to 
Canada. The application seeks authorization to export no greater than 
1,379,102 kilograms and 3.99 terabecquerels (TBq) of liquid low-level 
radioactive waste generated from medical isotope and 
radiopharmaceuticals production. The application requests an expiration 
date of December 1, 2026.
    In accordance with section 110.70 paragraph (b) of title 10 of the 
Code of Federal Regulations (10 CFR) the NRC is providing notice of the 
receipt of the application; providing the opportunity to submit written 
comments concerning the application; and providing the opportunity to 
request a hearing or petition for leave to intervene, for a period of 
30 days after publication of this notice in the Federal Register. A 
hearing request or petition for leave to intervene must include the 
information specified in 10 CFR 110.82(b). Any request for hearing or 
petition for leave

[[Page 51387]]

to intervene shall be served by the requestor or petitioner in 
accordance with 10 CFR 110.89(a), either by delivery, by mail, or filed 
with the NRC electronically in accordance with the NRC's E-Filing rule 
(72 FR 49139; August 28, 2007, as amended at 77 FR 46562; August 3, 
2012). Detailed guidance on making electronic submissions may be found 
in the Guidance for Electronic Submissions to the NRC and on the NRC 
website at https://www.nrc.gov/site-help/e-submittals.html.
    To comply with the procedural requirements of E-Filing, at least 10 
days prior to the filing deadline, the participant should contact the 
Office of the Secretary by email at [email protected], or by 
telephone at 301-415-1677, to (1) request a digital identification (ID) 
certificate, which allows the participant (or its counsel or 
representative) to digitally sign submissions and access the E-Filing 
system for any proceeding in which it is participating; and (2) advise 
the Secretary that the participant will be submitting a petition or 
other adjudicatory document (even in instances in which the 
participant, or its counsel or representative, already holds an NRC-
issued digital ID certificate). Based upon this information, the 
Secretary will establish an electronic docket for the hearing in this 
proceeding if the Secretary has not already established an electronic 
docket.
    The information concerning this application for an export license 
follows.

                     NRC Export License Application
------------------------------------------------------------------------
 
------------------------------------------------------------------------
                         Application Information
------------------------------------------------------------------------
Name of Applicant............  Perma-Fix Northwest Richland, Inc.
                                (PFNW).
Date of Application..........  July 2, 2021.
Date Received................  July 8, 2021.
Application No...............  XW028.
Docket No....................  11006420.
ADAMS Accession No...........  ML21190A131.
------------------------------------------------------------------------
                         Description of Material
------------------------------------------------------------------------
Material Type................  Radioactive material consisting of liquid
                                waste generated from medical isotope and
                                radiopharmaceuticals production. The
                                treated waste exported to Canada
                                consists mainly of thermal treatment
                                residual (ash) and some non-combustible
                                metal.
Total Quantity...............  Authorization to export a total maximum
                                quantity of waste will not exceed
                                1,379,102 kilograms. The maximum
                                isotopic activity returned will be 3.99
                                TBq. Radionuclides potentially present
                                in the waste include: Cd-115, Co-60, Cr-
                                51, Cu-64, ln-115m, K-42, Mo-93m, Mo-99,
                                Nb-91m, Nb-92m, Nb-95, Nb-95m, Nb-96, Re-
                                188, Sb-122, Sb-124, Ta-182, Ta-183, Tc-
                                99m, W-185, W-187, W-188, and Zr-89.
End Use......................  Disposal in Canada.
Country of Destination.......  Canada.
------------------------------------------------------------------------


    Dated: September 9, 2021.

    For the Nuclear Regulatory Commission.
David L. Skeen,
Deputy Director, Office of International Programs.
[FR Doc. 2021-19840 Filed 9-14-21; 8:45 am]
BILLING CODE 7590-01-P